MX2020009689A - Sistema para predecir el nivel de glucosa en la sangre de un paciente. - Google Patents

Sistema para predecir el nivel de glucosa en la sangre de un paciente.

Info

Publication number
MX2020009689A
MX2020009689A MX2020009689A MX2020009689A MX2020009689A MX 2020009689 A MX2020009689 A MX 2020009689A MX 2020009689 A MX2020009689 A MX 2020009689A MX 2020009689 A MX2020009689 A MX 2020009689A MX 2020009689 A MX2020009689 A MX 2020009689A
Authority
MX
Mexico
Prior art keywords
patient
variable
blood glucose
representative
model
Prior art date
Application number
MX2020009689A
Other languages
English (en)
Inventor
Eléonore Maeva Doron
UGALDE Hector- Manuel ROMERO
Stéphane Bonnet
Original Assignee
Commissariat Energie Atomique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique filed Critical Commissariat Energie Atomique
Publication of MX2020009689A publication Critical patent/MX2020009689A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/024—Measuring pulse rate or heart rate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/103—Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
    • A61B5/1118—Determining activity level
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4866—Evaluating metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/74—Details of notification to user or communication with user or patient; User input means
    • A61B5/746—Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A61M2005/1726—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure the body parameters being measured at, or proximate to, the infusion site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/63—Motion, e.g. physical activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dentistry (AREA)
  • Artificial Intelligence (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Signal Processing (AREA)
  • Emergency Medicine (AREA)
  • Optics & Photonics (AREA)
  • Primary Health Care (AREA)
  • Diabetes (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Obesity (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • External Artificial Organs (AREA)

Abstract

La invención se refiere a un sistema de control de glucosa en la sangre automatizado, que incluye una unidad de procesamiento y control capaz de predecir, con base en un modelo matemático, la tendencia futura de la glucosa en la sangre del paciente G(t), en donde el modelo toma como entradas: una variable EE(t) representativa de la variación en el tiempo del gasto energético del paciente; una variable IOB(t) representativa de la variación en el tiempo de la cantidad de insulina a bordo del paciente; y una variable COB(t) representativa de la variación en el tiempo de la cantidad de glucosa a bordo del paciente, y en donde el modelo matemático es un modelo de tipo caja negra , es decir, un modelo no fisiológico definido solamente por la observación de los efectos de las variables de entrada EE(t), IOB(t) y COB(t) sobre la variable de salida G(t), sin tomar en cuenta los diferentes mecanismos fisiológicos conocidos que operan en el cuerpo del paciente.
MX2020009689A 2018-03-20 2019-03-06 Sistema para predecir el nivel de glucosa en la sangre de un paciente. MX2020009689A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1852354A FR3079130A1 (fr) 2018-03-20 2018-03-20 Systeme de prediction de la glycemie d'un patient
PCT/FR2019/050505 WO2019180341A1 (fr) 2018-03-20 2019-03-06 Systeme de prediction de la glycemie d'un patient

Publications (1)

Publication Number Publication Date
MX2020009689A true MX2020009689A (es) 2020-11-11

Family

ID=63209473

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020009689A MX2020009689A (es) 2018-03-20 2019-03-06 Sistema para predecir el nivel de glucosa en la sangre de un paciente.

Country Status (8)

Country Link
US (1) US11883162B2 (es)
EP (1) EP3768166B1 (es)
JP (1) JP7286671B2 (es)
KR (1) KR102732622B1 (es)
CA (1) CA3094412C (es)
FR (1) FR3079130A1 (es)
MX (1) MX2020009689A (es)
WO (1) WO2019180341A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11158413B2 (en) 2018-04-23 2021-10-26 Medtronic Minimed, Inc. Personalized closed loop medication delivery system that utilizes a digital twin of the patient
US11147919B2 (en) 2018-04-23 2021-10-19 Medtronic Minimed, Inc. Methodology to recommend and implement adjustments to a fluid infusion device of a medication delivery system
FR3083076B1 (fr) * 2018-06-29 2023-04-07 Commissariat Energie Atomique Systeme automatise de controle de la glycemie d'un patient
US11986629B2 (en) 2019-06-11 2024-05-21 Medtronic Minimed, Inc. Personalized closed loop optimization systems and methods
FR3103372B1 (fr) 2019-11-27 2024-11-01 Commissariat Energie Atomique Système de régulation automatisée de glycémie
US20220233152A1 (en) * 2021-01-25 2022-07-28 Dexcom, Inc. Bayesian framework for personalized model identification and prediction of future blood glucose in type 1 diabetes using easily accessible patient data

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2556592C (en) * 2004-02-26 2014-01-28 Lars Gustaf Liljeryd Metabolic monitoring, a method and apparatus for indicating a health-related condition of a subject
US20060276771A1 (en) * 2005-06-06 2006-12-07 Galley Paul J System and method providing for user intervention in a diabetes control arrangement
WO2010135646A1 (en) * 2009-05-22 2010-11-25 Abbott Diabetes Care Inc. Usability features for integrated insulin delivery system
JP2012527981A (ja) * 2009-05-29 2012-11-12 ユニバーシティ オブ バージニア パテント ファウンデーション 糖尿病の開ループおよび閉ループ制御のためのシステムコーディネータおよびモジュールアーキテクチャ
WO2011050337A1 (en) 2009-10-22 2011-04-28 Abbott Diabetes Care Inc. Methods for modeling insulin therapy requirements
US20130231543A1 (en) * 2012-03-05 2013-09-05 Andrea Facchinetti Method to improve safety monitoring in type-1 diabetic patients by detecting in real-time failures of the glucose
WO2014172467A1 (en) * 2013-04-16 2014-10-23 Smartloop Llc Discretionary insulin delivery systems and methods
CN108495665B (zh) 2016-01-14 2021-04-09 比格福特生物医药公司 调整胰岛素输送速率

Also Published As

Publication number Publication date
KR102732622B1 (ko) 2024-11-21
EP3768166B1 (fr) 2022-02-09
WO2019180341A1 (fr) 2019-09-26
JP7286671B2 (ja) 2023-06-05
US20210100486A1 (en) 2021-04-08
US11883162B2 (en) 2024-01-30
FR3079130A1 (fr) 2019-09-27
JP2021518210A (ja) 2021-08-02
CA3094412C (fr) 2025-05-20
CA3094412A1 (fr) 2019-09-26
KR20200133231A (ko) 2020-11-26
EP3768166A1 (fr) 2021-01-27

Similar Documents

Publication Publication Date Title
MX2020009689A (es) Sistema para predecir el nivel de glucosa en la sangre de un paciente.
Parikh et al. Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society
Kabil et al. H2S and its role in redox signaling
AR109529A1 (es) Dispositivo de muestreo de fluido
BR112019003658A2 (pt) um dispositivo para obter uma amostra de sangue
MX379268B (es) Animales no humanos geneticamente modificados que expresan eritropoyetina de humano.
Zhang et al. Artificial Intelligence in Medicine
EA201790504A1 (ru) Монослой мононуклеарных клеток периферической крови или клеток костного мозга и его применение
Miles et al. Modern healthcare: a technical giant, yet an ethical child?
PE20190718A1 (es) Metodo y unidad para el tratamiento de la atmosfera de un lugar de almacenamiento de productos vegetales
GB2554591A (en) Clinical support system and method
MX2020014084A (es) Sistema automatizado para controlar el azucar en sangre de un paciente.
MX375652B (es) Casete de líquido con seguro de centrado que tiene una tolerancia a la inclinacion mejorada, asi como un aparato de tratamiento de sangre.
WO2015167768A8 (en) Injection sensor with feedback mechanism
RU2014134570A (ru) Устройство для фотогемотерапии животных
TR201820573A2 (tr) Yapay zekali doktor karar si̇stemi̇
ATE390916T1 (de) Vorrichtung zur freisetzung von medikamenten
Baeta et al. Culture and biomedical model: reflections in the health-disease process
Sewan Effect of PTU on some aspects of histological and physiological in fetus and pregnant rats (Rattus norvegicus)
Lavan et al. Comments on" intervention with the screening tool of older persons potentially inappropriate prescriptions/screening tool to alert doctors to right treatment criteria in elderly residents of a chronic geriatric facility: a randomized clinical trial"
Morales Osorio et al. Pain and physical modalities: a new paradigm in physiotherapy
Parreco et al. Supervised machine learning in critical care: The path forward
Amtmann et al. BMS letter to the editor# 1: introduction to the burn model system centers program
González-Block et al. Use of migrant's remittances from California on dependent's healthcare in Mexico
Bylander THE GOOD DOCTOR: A FATHER, A SON, AND THE EVOLUTION OF MEDICAL ETHICS